Search Within

Gynecology Disease Management Team

Formats
  1. Journal Article (2473)
  2. Meeting Abstract (2112)
  3. Book Section (226)
  4. Review (135)
  5. Editorial (88)
  6. Guidelines (39)
  7. Correspondence (19)
  8. Conference Paper (16)
  9. Miscellaneous (13)
  10. Research Letter (12)
  11. Book Whole (11)
Groups
  1. Surgery (2362)
  2. Department of Medicine (2268)
  3. Solid Tumor Oncology Division (2217)
  4. GDMT, Surgery (1974)
  5. GDMT, Medicine (1910)
  6. Gynecologic Medicine Service (1877)

More Groups

People
  1. Nadeem Abu-Rustum (902)
  2. Robert Soslow (797)
  3. Dennis Chi (716)
  4. Britta Weigelt (646)
  5. Carol Aghajanian (615)
  6. Mario Leitao (582)

More People

Years
  1. 2025 (161)
  2. 2024 (308)
  3. 2023 (332)
  4. 2022 (361)
  5. 2021 (308)
  6. 2020 (356)

More Years

Publications
  1. Gynecologic Oncology (950)
  2. Journal of Clinical Oncology (543)
  3. Modern Pathology (354)
  4. International Journal of Gynecological Cancer (321)
  5. Laboratory Investigation (311)
  6. International Journal of Radiation Oncology, Biology, Physics (223)

More Publications

Publishers
  1. Elsevier B.V. (1001)
  2. American Society of Clinical Oncology (598)
  3. Lippincott Williams & Wilkins (584)
  4. Elsevier Inc. (481)
  5. Nature Publishing Group (424)
  6. Nature Research (356)

More Publishers

Results (5144)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women
    Journal Article

    Hagemann, I. S.; Deng, W.; Zaino, R. J.; Powell, M. A.; Gunderson Jackson, C.; Cosgrove, C.; Mathews, C.; Pearl, M. L.; Waggoner, S.; Ghebre, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer
    Journal Article

    Zammarrelli, W. A. 3rd; Ma, W.; Espino, K.; Gordhandas, S.; Yeoshoua, E.; Ehmann, S.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N. R.; Aghajanian, C.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Response to letter to the editor, Gilks et al
    Correspondence

    Weigelt, B.; Mueller, J. J.; Ellenson, L. H.; Abu-Rustum, N. R.; Aghajanian, C.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Universal thromboprophylaxis in ovarian cancer patients before and after surgery?
    Editorial

    Moufarrij, S.; Havrilesky, L.; Jewell, E. L.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer
    Journal Article

    Pignata, S.; Bookman, M.; Sehouli, J.; Miller, A.; Penson, R. T.; Taskiran, C.; Anderson, C.; Hietanen, S.; Myers, T.; Madry, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • A Multiparameter molecular classifier to predict response to neoadjuvant lapatinib plus trastuzumab without chemotherapy in HER2+ breast cancer
    Journal Article

    Veeraraghavan, J.; Gutierrez, C.; De Angelis, C.; Davis, R.; Wang, T.; Pascual, T.; Selenica, P.; Sanchez, K.; Nitta, H.; Kapadia, M.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Younger patients with colon cancer are more likely to experience financial toxicity than older patients
    Miscellaneous

    Hakki, L.; Khan, A.; Ehrich, F.; Thompson, H. M.; Sokolowski, S.; Gönen, M.; Aviki, E. M.; Weiser, M. R.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Alliance A092104: A randomized phase 2/3 study of olaparib plus temozolomide versus investigator's choice for the treatment of patients with advanced uterine leiomyosarcoma after progression on prior chemotherapy
    Meeting Abstract

    Lacuna, K. P.; Mandrekar, S. J.; Allred, J. B.; Berg, S. A.; Hensley, M. L.; Van Tine, B. A.; George, S.; Schwartz, G. K.; Ingham, M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • ENGOT-EN20/GOG-3083/xport-EC-042: A phase 3, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with P53 wild-type, advanced or recurrent endometrial carcinoma
    Meeting Abstract

    Vergote, I.; Mirza, M. R.; Coleman, R. L.; Perez-Fidalgo, J. A.; Monk, B. J.; Valabrega, G.; Slomovitz, B. M.; Van Gorp, T.; Moore, K. N.; Sehouli, J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • CRI-CCTG-0003/IND.240: An immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC)
    Meeting Abstract

    Mackay, H.; Tinker, A.; Nelson, B.; Zamarin, D.; Odunsi, K.; Lheureux, S.; Ellard, S.; Smrke, A.; Gaudreau, P. O.; Faulkner, T.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save